Peer-reviewedCC BYDiagnostics (Basel, Switzerland)
Prognostic Significance of p53 Immunohistochemical Expression and Molecular Characterization of TP53 Variants in Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy
6 affiliations
- 1Department of Medical Oncology, Hospital de Denia, 03700 Alicante, Spain;
- 2PASAPTA Department, Veterinary School, Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, 46115 Valencia, Spain; (L.Á.); (I.T.-C.); (J.M.G.-B.)
- 3Department of Obstetrics and Gynecology, La Ribera Salud, 46015 Sueca, Spain;
- 4Department of Mathematics, Physics and Technological Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain; (R.B.-R.); (J.P.); (A.F.)
- 5School of Health Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, 45115 Valencia, Spain;
- 6Department of Pathology, Hospital de Denia, 03700 Alicante, Spain;
Related
- Immunohistochemical Classification and Prognostic Significance of Germinal Center-like and Memory Cell-like Subtypes of Follicular Lymphoma Using FOXP1, LMO2, CD22, and MUM1.
- Identification of Candidate Partner Cells in Tumor–Stromal Interactions by Histology-Based Spatial Analysis for Prognostic Stratification After Neoadjuvant Chemotherapy
- Splenic Enlargement During Neoadjuvant Chemotherapy for Gastric Cancer: Treatment-Related Phenomenon or Prognostic Biomarker?
- Prognostic significance of lymph node staging in esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
- Therapeutic outcomes and prognostic determinants of neoadjuvant chemotherapy plus interval debulking surgery compared with primary debulking surgery in advanced-stage epithelial ovarian cancer
BibTeX
@article{berenguermari2026prognostic,
title = {{Prognostic Significance of p53 Immunohistochemical Expression and Molecular Characterization of TP53 Variants in Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy}},
author = {Juan Ramón Berenguer-Marí and Luis Álvarez and Julia Sierra-Roca and Raquel Bosch-Romeu and Irene Tadeo-Cervera and Juan Pardo and Antonella Locascio and Juan Bautista Laforga and Antonio Falcó and Juan Manuel Gasent-Blesa and Joan Climent},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13663948},
note = {CC BY},
}
RIS
TY - JOUR
TI - Prognostic Significance of p53 Immunohistochemical Expression and Molecular Characterization of TP53 Variants in Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy
AU - Juan Ramón Berenguer-Marí
AU - Luis Álvarez
AU - Julia Sierra-Roca
AU - Raquel Bosch-Romeu
AU - Irene Tadeo-Cervera
AU - Juan Pardo
AU - Antonella Locascio
AU - Juan Bautista Laforga
AU - Antonio Falcó
AU - Juan Manuel Gasent-Blesa
AU - Joan Climent
PY - 2026
DA - 2026/10/01
JO - Diagnostics (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13663948
SN - 2075-4418
ER -